Abstract:Background The COVID-19 pandemic adversely affected young adults' reproductive health services, resulting in fluctuating positivity rates prompting a need to better understand the prevalence and trends of sexually transmitted infections in this young adult 18-24 years cohort seen a large urban free community clinic system of nine school-based and family planning clinics. Methods Retrospective chart review of patients categorized based on the year of their visit: 2019 (pre-pandemic), 2020 (phase 1), and 2021 (phase 2). Time-to-treatment (TTT) was evaluated based on the date of screening, matched with STI diagnoses and dispensed medications. To ensure data accuracy, we identified potential outliers with TTT exceeding 30 days and conducted targeted chart reviews. Patients for whom treatment could not be confirmed through this process were classified as untreated. Results The study included 26,895 patients over three years, with 18% fewer patients seen in phase 1 compared to the pre-pandemic year. Fewer patients were tested and tested positive for both CT and GC in 2020 (930 of 5702, 16.3%; 332 of 5768, 5.8%) than in 2019 (1244 of 6767,18.4%; 412 of 6762, 6.1%) and 2021 (1179 of 6271,18.8%; 604 of 6264, 9.6%) (p< 0.001). Proportion of tested patients with positive syphilis and HIV tests remained similar pre-COVID (53 of 5977, 0.0088%; 8 of 5974, 0.0013%), in phase 1 (45 of 5013, 0.0089%; 8 of 4925, 0.0016%), and phase 2 (60 of 5679, 0.01%; 10 of 5630, 0.0017%) (p = 0.581 and 0.83). Time-to-treatment of positive CT results was shortest pre-pandemic at 6.6 days (SD 20.2) vs. 7.7 days (SD 43.7) in phase 1, and 8 days (SD 26.9) in phase 2, though the differences were not statistically significant (p = 0.056). Fewer patients went untreated for CT in 2020 and 2021 (2.8% and 2.2%) than in 2019 (p= 0.004). In contrast, TTT for GC was shortest in 2020 (2.9 days, SD 10.3) as compared with the pre-pandemic year (4.6 days, SD 15.8) and phase 2 of the pandemic (4.7 days, SD 14.4) (p = 0.0011). No significant differences were found in patients untreated for GC through the three years of study (2.4%, 2.1%, and 3.8%, p = 0.253). Conclusions While STI testing rates among young adults declined during the start of the COVID-19 pandemic, positivity rates for GC and CT also decreased. GC and CT positivity increased again in phase 2. Adverse treatment outcomes, such as prolonged TTT or untreated cases, were not observed for CT or GC in phases 1 or 2. There were no significant changes in the positivity rates of HIV and syphilis over the three years of study. While some studies have reported increased rates of syphilis and gonorrhea in post pandemic phases, this was not observed in this cohort.

Sharp increase in gonorrhoea notifications among young people, EU/EEA, July 2022 to June 2023

Epidemiology of gonorrhoea: systematic review, meta-analyses, and meta-regressions, World Health Organization European Region, 1949 to 2021

Gonorrhoea on the rise in Denmark since 2022: distinct clones drive increase in heterosexual individuals

Increased trends in reported sexually transmitted infections according to age groups and sex in Spain, 2016–2022

Sexually Transmitted Infections in Italian Young and Adult People: A Worrying Positive Trend Hidden by COVID-19 Epidemic

Gonorrhoea in 21st century--international and Polish situation

Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20

Rising incidence of gonorrhea in Taiwan amid the COVID-19 pandemic: a nationwide surveillance study

Changes in testing and incidence of Chlamydia trachomatis and Neisseria gonorrhoeae – the possible impact of the COVID-19 pandemic in the three Scandinavian countries

Increasing Incidence Rates of Sexually Transmitted Infections from 2010 to 2019: an Analysis of Temporal Trends by Geographical Regions and Age Groups from the 2019 Global Burden of Disease Study

Sexually Transmitted Infections in Adolescents and Young Adults: A Cross Section of Public Health

Increased incidence of adult gonococcal keratoconjunctivitis at two tertiary eye hospitals in Western Europe: clinical features, complications and antimicrobial susceptibility

65. Impact of COVID-19 pandemic on STIs in young adults

International travels and transmission of multidrug resistant Neisseria gonorrhoeae in Europe: A systematic review

Performance of Sexually Transmitted Disease Laboratories for Neisseria gonorrhoeae Detection in Southern China From 2020 Through 2022

Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy

Self-reported sexually transmitted infections and associated risk factors among female university students

The increase in invasive bacterial infections with respiratory transmission in Germany, 2022/2023

Development of a Novel Fluorescent-Based Lateral Flow Assay for the Detection of Neisseria gonorrhoeae at the Point of Care

Incidence Trends of Five Common Sexually Transmitted Infections Excluding HIV From 1990 to 2019 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2019

Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012